Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide vs Calcitonin in Chinese Osteoporosis Patients
NCT00414973Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2006
- Primary completion
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of teriparatide in osteoporosis, sponsored by Eli Lilly and Company. Started Dec 2006; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00414973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414973.